Imunon, Inc. Common Stock and Additional Paid-In Capital
Imunon, Inc. (IMNN) had Common Stock and Additional Paid-In Capital of $430.34 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStocksIncludingAdditionalPaidInCapital · last filed 2026-08-11
- 2026-06-30: Common Stocks, Including Additional Paid in Capital $430.34M.
- 2025-12-31: Common Stocks, Including Additional Paid in Capital $428.41M.
| Period end | Common Stocks, Including Additional Paid in Capital |
|---|---|
| 2026-06-30 | $430.34M 10-Q · filed 2026-08-11 |
| 2025-12-31 | $428.41M 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |